| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.42e-08 | 14 | 50 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.23e-06 | 9 | 50 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.23e-06 | 9 | 50 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 3.20e-06 | 12 | 50 | 3 | GO:0004706 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.25e-06 | 46 | 50 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.75e-05 | 129 | 50 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.73e-05 | 151 | 50 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 3.85e-05 | 152 | 50 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 4.14e-05 | 27 | 50 | 3 | GO:0004709 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 9.05e-05 | 182 | 50 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 9.53e-05 | 184 | 50 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.79e-04 | 334 | 50 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.07e-04 | 343 | 50 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | amide binding | 8.89e-04 | 299 | 50 | 5 | GO:0033218 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 9.64e-04 | 459 | 50 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | actin binding | 1.20e-03 | 479 | 50 | 6 | GO:0003779 | |
| GeneOntologyMolecularFunction | channel activity | 1.91e-03 | 525 | 50 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | cullin family protein binding | 1.92e-03 | 26 | 50 | 2 | GO:0097602 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.93e-03 | 526 | 50 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.07e-03 | 27 | 50 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.13e-03 | 102 | 50 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A CACNA1B CACNA1E ABCA13 ABCB6 CACNA1I GRIN2A LASP1 CHRND | 2.38e-03 | 1180 | 50 | 9 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 3.42e-03 | 793 | 50 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A CACNA1B CACNA1E ABCA13 ABCB6 CACNA1I GRIN2A LASP1 CHRND | 4.29e-03 | 1289 | 50 | 9 | GO:0005215 |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 5.20e-03 | 43 | 50 | 2 | GO:0005231 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.00e-03 | 465 | 50 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 6.06e-03 | 664 | 50 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.70e-03 | 49 | 50 | 2 | GO:0140359 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.08e-07 | 48 | 50 | 5 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.08e-07 | 48 | 50 | 5 | GO:1902656 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 8.81e-07 | 217 | 50 | 7 | GO:0097553 | |
| GeneOntologyBiologicalProcess | calcium ion import | 3.91e-06 | 98 | 50 | 5 | GO:0070509 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 2.38e-05 | 142 | 50 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 2.38e-05 | 142 | 50 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 4.19e-05 | 392 | 50 | 7 | GO:0070588 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 2.13e-04 | 509 | 50 | 7 | GO:0006816 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 2.32e-04 | 230 | 50 | 5 | GO:0098739 | |
| GeneOntologyBiologicalProcess | response to pain | 2.57e-04 | 51 | 50 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1A CACNA1B EPO CACNA1E ABCB6 CACNA1I GRIN2A LASP1 GRM6 CHRND | 2.91e-04 | 1115 | 50 | 10 | GO:0034220 |
| GeneOntologyBiologicalProcess | response to amyloid-beta | 4.37e-04 | 61 | 50 | 3 | GO:1904645 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.39e-06 | 46 | 50 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1A CACNA1B CACNA1E SNTG1 ITGA6 ABCB6 CACNA1I GRIN2A ITGA1 CHRND | 1.38e-05 | 785 | 50 | 10 | GO:0098797 |
| GeneOntologyCellularComponent | calcium channel complex | 2.79e-05 | 73 | 50 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.32e-04 | 523 | 50 | 7 | GO:1902495 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.73e-04 | 378 | 50 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | transporter complex | 3.15e-04 | 550 | 50 | 7 | GO:1990351 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.94e-04 | 405 | 50 | 6 | GO:0045211 | |
| GeneOntologyCellularComponent | cation channel complex | 2.39e-03 | 235 | 50 | 4 | GO:0034703 | |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1A CACNA1B CACNA1E SNTG1 ITGA6 ABCB6 CACNA1I GRIN2A ITGA1 CHRND | 2.53e-03 | 1498 | 50 | 10 | GO:0098796 |
| GeneOntologyCellularComponent | synaptic membrane | 2.57e-03 | 583 | 50 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | integrin complex | 2.66e-03 | 32 | 50 | 2 | GO:0008305 | |
| GeneOntologyCellularComponent | postsynapse | 2.67e-03 | 1018 | 50 | 8 | GO:0098794 | |
| Domain | VDCCAlpha1 | 9.43e-09 | 10 | 50 | 4 | IPR002077 | |
| Domain | SH3_9 | 5.99e-08 | 78 | 50 | 6 | PF14604 | |
| Domain | MLK1/MLK2/MLK4 | 7.21e-08 | 4 | 50 | 3 | IPR016231 | |
| Domain | MAP3K10 | 7.21e-08 | 4 | 50 | 3 | IPR015785 | |
| Domain | VDCC_a1su_IQ | 6.27e-07 | 7 | 50 | 3 | IPR014873 | |
| Domain | GPHH | 6.27e-07 | 7 | 50 | 3 | PF16905 | |
| Domain | GPHH_dom | 6.27e-07 | 7 | 50 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 6.27e-07 | 7 | 50 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 6.27e-07 | 7 | 50 | 3 | PF08763 | |
| Domain | SH3 | 1.64e-06 | 216 | 50 | 7 | SM00326 | |
| Domain | SH3 | 1.64e-06 | 216 | 50 | 7 | PS50002 | |
| Domain | SH3_domain | 1.86e-06 | 220 | 50 | 7 | IPR001452 | |
| Domain | Channel_four-helix_dom | 1.62e-05 | 57 | 50 | 4 | IPR027359 | |
| Domain | - | 1.62e-05 | 57 | 50 | 4 | 1.20.120.350 | |
| Domain | NEBU | 4.20e-05 | 4 | 50 | 2 | SM00227 | |
| Domain | Nebulin | 4.20e-05 | 4 | 50 | 2 | PF00880 | |
| Domain | Nebulin | 4.20e-05 | 4 | 50 | 2 | IPR013998 | |
| Domain | NEBULIN | 4.20e-05 | 4 | 50 | 2 | PS51216 | |
| Domain | Nebulin_repeat | 4.20e-05 | 4 | 50 | 2 | IPR000900 | |
| Domain | SH3_1 | 7.56e-05 | 164 | 50 | 5 | PF00018 | |
| Domain | Ion_trans_dom | 2.44e-04 | 114 | 50 | 4 | IPR005821 | |
| Domain | Ion_trans | 2.44e-04 | 114 | 50 | 4 | PF00520 | |
| Domain | Integrin_alpha_C_CS | 8.23e-04 | 16 | 50 | 2 | IPR018184 | |
| Domain | Integrin_alpha-2 | 1.05e-03 | 18 | 50 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 1.05e-03 | 18 | 50 | 2 | PF08441 | |
| Domain | Integrin_alpha | 1.05e-03 | 18 | 50 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 1.05e-03 | 18 | 50 | 2 | PS00242 | |
| Domain | Int_alpha_beta-p | 1.17e-03 | 19 | 50 | 2 | IPR013519 | |
| Domain | Int_alpha | 1.17e-03 | 19 | 50 | 2 | SM00191 | |
| Domain | FG_GAP | 1.57e-03 | 22 | 50 | 2 | PS51470 | |
| Domain | SH3_2 | 1.58e-03 | 86 | 50 | 3 | IPR011511 | |
| Domain | SH3_2 | 1.58e-03 | 86 | 50 | 3 | PF07653 | |
| Domain | FG-GAP | 1.87e-03 | 24 | 50 | 2 | PF01839 | |
| Domain | FG-GAP | 1.87e-03 | 24 | 50 | 2 | IPR013517 | |
| Domain | Integrin_dom | 2.03e-03 | 25 | 50 | 2 | IPR032695 | |
| Domain | - | 2.36e-03 | 27 | 50 | 2 | 2.130.10.80 | |
| Domain | Gal_Oxidase_b-propeller | 3.73e-03 | 34 | 50 | 2 | IPR015916 | |
| Domain | ANF_lig-bd_rcpt | 4.41e-03 | 37 | 50 | 2 | IPR001828 | |
| Domain | ANF_receptor | 4.41e-03 | 37 | 50 | 2 | PF01094 | |
| Domain | Peripla_BP_I | 4.89e-03 | 39 | 50 | 2 | IPR028082 | |
| Domain | BTB-kelch_protein | 5.91e-03 | 43 | 50 | 2 | IPR017096 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 6.00e-03 | 138 | 50 | 3 | IPR001245 | |
| Domain | AAA+_ATPase | 6.75e-03 | 144 | 50 | 3 | IPR003593 | |
| Domain | AAA | 6.75e-03 | 144 | 50 | 3 | SM00382 | |
| Domain | P-loop_NTPase | 7.06e-03 | 848 | 50 | 7 | IPR027417 | |
| Domain | ABC_tran | 7.32e-03 | 48 | 50 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 7.32e-03 | 48 | 50 | 2 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 7.62e-03 | 49 | 50 | 2 | PS00211 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.83e-07 | 23 | 38 | 4 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 5.45e-07 | 25 | 38 | 4 | M47948 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.94e-06 | 11 | 38 | 3 | M47958 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 2.94e-06 | 11 | 38 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 2.94e-06 | 11 | 38 | 3 | M26913 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 3.41e-06 | 87 | 38 | 5 | M6856 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY | 3.91e-06 | 12 | 38 | 3 | M47929 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.09e-04 | 178 | 38 | 5 | M2890 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.41e-04 | 211 | 38 | 5 | MM14502 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 2.70e-04 | 47 | 38 | 3 | M19708 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 7.43e-04 | 270 | 38 | 5 | M15514 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 9.38e-04 | 17 | 38 | 2 | M47905 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 9.87e-04 | 73 | 38 | 3 | MM16641 | |
| Pubmed | 4.74e-10 | 9 | 50 | 4 | 16382099 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 38996073 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 2.80e-09 | 3 | 50 | 3 | 24523520 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 1.12e-08 | 4 | 50 | 3 | 32616470 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 1.12e-08 | 4 | 50 | 3 | 37141091 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 8825650 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 11296258 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 15451373 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 5.57e-08 | 6 | 50 | 3 | 35324301 | |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 9238069 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 5.57e-08 | 6 | 50 | 3 | 12827191 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 9.75e-08 | 7 | 50 | 3 | 35176221 | |
| Pubmed | 1.56e-07 | 8 | 50 | 3 | 28330839 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.69e-07 | 38 | 50 | 4 | 30786075 | |
| Pubmed | 1.26e-06 | 15 | 50 | 3 | 20188150 | ||
| Pubmed | 1.26e-06 | 15 | 50 | 3 | 24453333 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 15610184 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 2.03e-06 | 2 | 50 | 2 | 23426690 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 16381801 | ||
| Pubmed | The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. | 2.03e-06 | 2 | 50 | 2 | 11416147 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 38155373 | ||
| Pubmed | Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. | 2.03e-06 | 2 | 50 | 2 | 12074836 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8477742 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 15050706 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8536694 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23376566 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 29466725 | ||
| Pubmed | Mice lacking both mixed-lineage kinase genes Mlk1 and Mlk2 retain a wild type phenotype. | 6.07e-06 | 3 | 50 | 2 | 18414056 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 18032737 | ||
| Pubmed | Targeting Cul3-scaffold E3 ligase complex via KLHL substrate adaptors for cancer therapy. | 6.07e-06 | 3 | 50 | 2 | 33872809 | |
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 6.07e-06 | 3 | 50 | 2 | 24394417 | |
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 6.07e-06 | 3 | 50 | 2 | 29208674 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 9698453 | ||
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 6.07e-06 | 3 | 50 | 2 | 26507659 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 8195146 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 26283199 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 31253182 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 15679046 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 15728831 | ||
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 1.21e-05 | 4 | 50 | 2 | 15953418 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 23985323 | ||
| Pubmed | The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. | 1.21e-05 | 4 | 50 | 2 | 25483588 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 16787652 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 31515271 | ||
| Pubmed | A β-amyloid oligomer directly modulates P/Q-type calcium currents in Xenopus oocytes. | 3.03e-05 | 6 | 50 | 2 | 21883149 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 10328888 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 1690718 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 12883474 | ||
| Pubmed | 3.80e-05 | 45 | 50 | 3 | 25979088 | ||
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 11767049 | ||
| Pubmed | Integrin expression patterns during early limb muscle development in the mouse. | 4.23e-05 | 7 | 50 | 2 | 14516674 | |
| Pubmed | Developmental regulation of integrin expression at the time of implantation in the mouse embryo. | 5.64e-05 | 8 | 50 | 2 | 8306881 | |
| Pubmed | Expression of beta 1 integrin complexes on the surface of unfertilized mouse oocyte. | 5.64e-05 | 8 | 50 | 2 | 7691492 | |
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 9553049 | ||
| Pubmed | Characterization of integrin engagement during defined human embryonic stem cell culture. | 7.25e-05 | 9 | 50 | 2 | 19933311 | |
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 1693624 | ||
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 10094488 | ||
| Pubmed | Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex. | 7.25e-05 | 9 | 50 | 2 | 14504284 | |
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 25808196 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 18054859 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 17543862 | ||
| Pubmed | Integrin repertoire on myogenic cells changes during the course of primary myogenesis in the mouse. | 1.10e-04 | 11 | 50 | 2 | 15739233 | |
| Pubmed | Immunolocalization of extracellular matrix components and integrins during mouse liver development. | 1.10e-04 | 11 | 50 | 2 | 15368439 | |
| Pubmed | Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. | 1.10e-04 | 11 | 50 | 2 | 14528312 | |
| Pubmed | 1.32e-04 | 12 | 50 | 2 | 19995937 | ||
| Pubmed | 1.41e-04 | 347 | 50 | 5 | 17114649 | ||
| Pubmed | 1.56e-04 | 13 | 50 | 2 | 20563599 | ||
| Pubmed | 1.82e-04 | 14 | 50 | 2 | 21228161 | ||
| Pubmed | 1.95e-04 | 199 | 50 | 4 | 23382691 | ||
| Pubmed | MAP3Ks as central regulators of cell fate during development. | 2.10e-04 | 15 | 50 | 2 | 18855897 | |
| Pubmed | 2.10e-04 | 15 | 50 | 2 | 15366018 | ||
| Pubmed | Integrin requirement for hippocampal synaptic plasticity and spatial memory. | 2.40e-04 | 16 | 50 | 2 | 12904471 | |
| Pubmed | USP25 regulates Wnt signaling by controlling the stability of tankyrases. | 2.40e-04 | 16 | 50 | 2 | 28619731 | |
| Pubmed | 2.72e-04 | 87 | 50 | 3 | 37495603 | ||
| Pubmed | Identification of substrates of SMURF1 ubiquitin ligase activity utilizing protein microarrays. | 2.72e-04 | 87 | 50 | 3 | 20804422 | |
| Pubmed | Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. | 3.05e-04 | 18 | 50 | 2 | 19686679 | |
| Pubmed | 3.41e-04 | 19 | 50 | 2 | 24564958 | ||
| Pubmed | 3.55e-04 | 233 | 50 | 4 | 37704626 | ||
| Pubmed | 4.59e-04 | 22 | 50 | 2 | 35245678 | ||
| Pubmed | 4.59e-04 | 22 | 50 | 2 | 9811459 | ||
| Pubmed | 5.03e-04 | 23 | 50 | 2 | 33130828 | ||
| Pubmed | Estrogen-dependent uterine secretion of osteopontin activates blastocyst adhesion competence. | 5.03e-04 | 23 | 50 | 2 | 23152823 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 5.48e-04 | 24 | 50 | 2 | 35746896 | |
| Pubmed | Dimerization quality control ensures neuronal development and survival. | 5.48e-04 | 24 | 50 | 2 | 30190310 | |
| Pubmed | 5.48e-04 | 24 | 50 | 2 | 22534482 | ||
| Pubmed | 6.59e-04 | 486 | 50 | 5 | 20936779 | ||
| Pubmed | 6.71e-04 | 276 | 50 | 4 | 28319085 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 6.95e-04 | 27 | 50 | 2 | 31541017 | |
| Pubmed | Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome. | 6.95e-04 | 27 | 50 | 2 | 18468998 | |
| Pubmed | 8.59e-04 | 30 | 50 | 2 | 32562661 | ||
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 9.17e-04 | 31 | 50 | 2 | 11431694 | |
| Pubmed | 9.77e-04 | 32 | 50 | 2 | 19320717 | ||
| Pubmed | A Role for Sensory end Organ-Derived Signals in Regulating Muscle Spindle Proprioceptor Phenotype. | 9.77e-04 | 32 | 50 | 2 | 30926747 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.07e-03 | 139 | 50 | 3 | 16985003 | |
| Pubmed | 1.24e-03 | 36 | 50 | 2 | 38078651 | ||
| Pubmed | Ion channel expression in the developing enteric nervous system. | 1.31e-03 | 37 | 50 | 2 | 25798587 | |
| Pubmed | 1.41e-03 | 153 | 50 | 3 | 10718198 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q23 | 1.55e-03 | 53 | 50 | 2 | chr2q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq24 | 3.57e-03 | 81 | 50 | 2 | chrXq24 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.15e-07 | 26 | 37 | 4 | 253 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.55e-05 | 24 | 37 | 3 | 654 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 6.11e-04 | 18 | 37 | 2 | 1160 | |
| GeneFamily | Kelch like|BTB domain containing | 3.33e-03 | 42 | 37 | 2 | 617 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 4.69e-03 | 50 | 37 | 2 | 1293 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.32e-03 | 394 | 37 | 4 | 471 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.77e-07 | 148 | 50 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.83e-06 | 198 | 50 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.83e-06 | 198 | 50 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.83e-06 | 198 | 50 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.97e-06 | 200 | 50 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 2.18e-05 | 146 | 50 | 4 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-05 | 150 | 50 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-05 | 154 | 50 | 4 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-05 | 154 | 50 | 4 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.90e-05 | 157 | 50 | 4 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.05e-05 | 159 | 50 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-05 | 162 | 50 | 4 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.69e-05 | 167 | 50 | 4 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.87e-05 | 169 | 50 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 171 | 50 | 4 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 171 | 50 | 4 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175|Adult / Lineage, Cell type, age group and donor | 4.63e-05 | 177 | 50 | 4 | c9f269765c7d5d29caab75910e51645606ed562e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.73e-05 | 178 | 50 | 4 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-05 | 180 | 50 | 4 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-05 | 180 | 50 | 4 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 182 | 50 | 4 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.38e-05 | 184 | 50 | 4 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 185 | 50 | 4 | 512a195ebbae445afe3722a3943020080daf2f3c | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-05 | 186 | 50 | 4 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 186 | 50 | 4 | 41f1674afc17661eccaa779cdeb663db5e45685d | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 186 | 50 | 4 | aa006650cf21a2c51dfe1091681f67fdad939107 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-05 | 186 | 50 | 4 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.73e-05 | 187 | 50 | 4 | e9aa0a5a0f8e2593de63e83b56b53ae33e60af49 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 5.73e-05 | 187 | 50 | 4 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.73e-05 | 187 | 50 | 4 | 61b8a53f29bb8b33c69f680b8359a1143a23999d | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.85e-05 | 188 | 50 | 4 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 5.97e-05 | 189 | 50 | 4 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 189 | 50 | 4 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.97e-05 | 189 | 50 | 4 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.22e-05 | 191 | 50 | 4 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 191 | 50 | 4 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.22e-05 | 191 | 50 | 4 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.22e-05 | 191 | 50 | 4 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 6.22e-05 | 191 | 50 | 4 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.22e-05 | 191 | 50 | 4 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.22e-05 | 191 | 50 | 4 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.22e-05 | 191 | 50 | 4 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.22e-05 | 191 | 50 | 4 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.22e-05 | 191 | 50 | 4 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.22e-05 | 191 | 50 | 4 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.22e-05 | 191 | 50 | 4 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 6.22e-05 | 191 | 50 | 4 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.22e-05 | 191 | 50 | 4 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.22e-05 | 191 | 50 | 4 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.22e-05 | 191 | 50 | 4 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.22e-05 | 191 | 50 | 4 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30） | 6.22e-05 | 191 | 50 | 4 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 6.22e-05 | 191 | 50 | 4 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.22e-05 | 191 | 50 | 4 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.35e-05 | 192 | 50 | 4 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 6.35e-05 | 192 | 50 | 4 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 6.35e-05 | 192 | 50 | 4 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-05 | 193 | 50 | 4 | 5d42979d811ee13a07dee08a3743a90776017cb4 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-05 | 193 | 50 | 4 | 95e64b9580d30c28702639a043a8b72ce1cadeb6 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-05 | 193 | 50 | 4 | 97c0730aad9135ac681250b3871cc094a28f80a7 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.48e-05 | 193 | 50 | 4 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 194 | 50 | 4 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 194 | 50 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.61e-05 | 194 | 50 | 4 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-05 | 194 | 50 | 4 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.61e-05 | 194 | 50 | 4 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 6.61e-05 | 194 | 50 | 4 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.74e-05 | 195 | 50 | 4 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.74e-05 | 195 | 50 | 4 | 8ab45ab94c722c4aef0229ee1121cd744bf659dd | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.74e-05 | 195 | 50 | 4 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.74e-05 | 195 | 50 | 4 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.74e-05 | 195 | 50 | 4 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.88e-05 | 196 | 50 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 6.88e-05 | 196 | 50 | 4 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 6.88e-05 | 196 | 50 | 4 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-05 | 197 | 50 | 4 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.01e-05 | 197 | 50 | 4 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-05 | 197 | 50 | 4 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-05 | 197 | 50 | 4 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.01e-05 | 197 | 50 | 4 | 81718164c9802ee20c860ffbda7e62d5e9a76f16 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.01e-05 | 197 | 50 | 4 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-05 | 197 | 50 | 4 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.15e-05 | 198 | 50 | 4 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.15e-05 | 198 | 50 | 4 | 40c2171e79f578c9116d872c189f953dc61d052d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.15e-05 | 198 | 50 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.15e-05 | 198 | 50 | 4 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 7.29e-05 | 199 | 50 | 4 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.44e-05 | 200 | 50 | 4 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Capillary|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 7.44e-05 | 200 | 50 | 4 | 6c0498a5868891e8e22c03469d00669b20249b1a | |
| ToppCell | medial-2-Endothelial-Capillary_Intermediate_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.44e-05 | 200 | 50 | 4 | a8adf5902540f6bb15b72efbb9c389b59d67e001 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.44e-05 | 200 | 50 | 4 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Differentiating_Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.44e-05 | 200 | 50 | 4 | f7b4581d958afbd68f9045af619aaca0ab463439 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.44e-05 | 200 | 50 | 4 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.44e-05 | 200 | 50 | 4 | 3ef7b7728615710c691aed8977e2582f19692cf9 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.44e-05 | 200 | 50 | 4 | 7020045b933cb104fb99b79524cb0d4734b8636d | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.44e-05 | 200 | 50 | 4 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.44e-05 | 200 | 50 | 4 | e9913511a129bb3cee85e7ebf565b951dab91542 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.44e-05 | 200 | 50 | 4 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.44e-05 | 200 | 50 | 4 | 707148e01e961097819a05437a842b7d3bf72b0a | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.85e-04 | 114 | 50 | 3 | 2cc5d2da5573650c5232a01e2d2128082c4bffcb | |
| Drug | 3,4-dihydroquinazoline | 2.83e-10 | 6 | 49 | 4 | CID000583065 | |
| Drug | AC1L2VU3 | 9.25e-09 | 12 | 49 | 4 | CID000129572 | |
| Drug | Dantrolene-13C3 | 2.52e-08 | 145 | 49 | 7 | CID000002951 | |
| Drug | butamben | 2.54e-08 | 15 | 49 | 4 | CID000002482 | |
| Drug | pentasulfane | 3.38e-08 | 16 | 49 | 4 | CID000448216 | |
| Drug | AC 110 | 3.74e-08 | 4 | 49 | 3 | CID000022860 | |
| Drug | gabapentin | 7.24e-08 | 169 | 49 | 7 | CID000003446 | |
| Drug | alpha-sialylcholesterol | 1.86e-07 | 6 | 49 | 3 | CID000133976 | |
| Drug | APMPA | 3.26e-07 | 7 | 49 | 3 | CID000512300 | |
| Drug | DCG-IV | 3.52e-07 | 68 | 49 | 5 | CID000115114 | |
| Drug | nimodipine | 6.71e-07 | 145 | 49 | 6 | CID000004497 | |
| Drug | CNS 1145 | 7.40e-07 | 33 | 49 | 4 | CID000190902 | |
| Drug | IHC-64 | 7.40e-07 | 33 | 49 | 4 | CID000162753 | |
| Drug | 3-7a | 1.06e-06 | 36 | 49 | 4 | CID011987860 | |
| Drug | 3,4-diaminopyridine | 1.32e-06 | 38 | 49 | 4 | CID000005918 | |
| Drug | hexachlorophene | 1.43e-06 | 90 | 49 | 5 | CID000003598 | |
| Drug | 2-amino-4-phosphonobutyric acid | 1.51e-06 | 91 | 49 | 5 | CID000002207 | |
| Drug | leys | 1.53e-06 | 11 | 49 | 3 | CID000484683 | |
| Drug | riluzole | 1.95e-06 | 174 | 49 | 6 | CID000005070 | |
| Drug | loperamide | 3.08e-06 | 105 | 49 | 5 | CID000003954 | |
| Drug | baclofen | 3.34e-06 | 191 | 49 | 6 | CID000002284 | |
| Drug | tetradotoxin | 3.35e-06 | 428 | 49 | 8 | CID000020382 | |
| Drug | norcepharadione B | 4.54e-06 | 2 | 49 | 2 | CID000189168 | |
| Drug | aristolactam AII | 4.54e-06 | 2 | 49 | 2 | CID000148657 | |
| Drug | alkosin | 4.54e-06 | 2 | 49 | 2 | CID005488638 | |
| Drug | piperolactam A | 4.54e-06 | 2 | 49 | 2 | CID003081016 | |
| Drug | lamotrigine | 5.02e-06 | 116 | 49 | 5 | CID000003878 | |
| Drug | Verapamil | 5.14e-06 | 16 | 49 | 3 | DB00661 | |
| Drug | DPCPX | 5.23e-06 | 117 | 49 | 5 | CID000001329 | |
| Drug | Cinildipine | 6.40e-06 | 56 | 49 | 4 | CID000002752 | |
| Drug | nefiracetam | 6.40e-06 | 56 | 49 | 4 | CID000071157 | |
| Drug | nilvadipine | 8.45e-06 | 60 | 49 | 4 | CID000004494 | |
| Drug | N6-Me-dAdo | 8.86e-06 | 19 | 49 | 3 | CID000168948 | |
| Drug | pranidipine | 8.86e-06 | 19 | 49 | 3 | CID006436048 | |
| Drug | GR 64349 | 8.86e-06 | 19 | 49 | 3 | CID003036081 | |
| Drug | IAA-94 | 9.03e-06 | 61 | 49 | 4 | CID000003667 | |
| Drug | verapamil | 9.03e-06 | 490 | 49 | 8 | CID000002520 | |
| Drug | lercanidipine | 1.03e-05 | 63 | 49 | 4 | CID000065866 | |
| Drug | AC1L1TJF | 1.24e-05 | 66 | 49 | 4 | CID000003377 | |
| Drug | gallopamil | 1.31e-05 | 67 | 49 | 4 | CID000001234 | |
| Drug | AC1L2AC7 | 1.48e-05 | 69 | 49 | 4 | CID000068733 | |
| Drug | nicardipine | 1.49e-05 | 145 | 49 | 5 | CID000004473 | |
| Drug | LY320135 | 1.61e-05 | 23 | 49 | 3 | CID005311257 | |
| Drug | alpha-conotoxin SI | 1.61e-05 | 23 | 49 | 3 | CID000163979 | |
| Drug | Barium | 1.75e-05 | 72 | 49 | 4 | ctd:D001464 | |
| Drug | CAS 298-57-7 | 1.85e-05 | 73 | 49 | 4 | CID000002761 | |
| Drug | dopamine | CACNA1A CACNA1B CACNA1E ANPEP SUPT5H GRIN2A GRM6 SNRPE CHRND | 1.88e-05 | 715 | 49 | 9 | CID000000681 |
| Drug | procaine | 1.93e-05 | 153 | 49 | 5 | CID000004914 | |
| Drug | 1,3-dipropylxanthine | 1.95e-05 | 74 | 49 | 4 | CID000169317 | |
| Drug | ethosuximide | 1.95e-05 | 74 | 49 | 4 | CID000003291 | |
| Drug | nisoldipine | 2.40e-05 | 78 | 49 | 4 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.53e-05 | 79 | 49 | 4 | CID005287890 | |
| Drug | GDP-b-S | 2.54e-05 | 162 | 49 | 5 | CID000643998 | |
| Drug | mAHP | 2.64e-05 | 27 | 49 | 3 | CID000220531 | |
| Drug | eniluracil | 2.64e-05 | 27 | 49 | 3 | CID000043157 | |
| Drug | NSC755875 | 2.77e-05 | 165 | 49 | 5 | CID000002215 | |
| Drug | phorbol acetate myristate | CACNA1A CACNA1B EPO CACNA1E MBTPS1 ANPEP INHBB ITGA6 CACNA1I ITGA1 MUC4 MOCOS | 3.04e-05 | 1399 | 49 | 12 | CID000004792 |
| Drug | lavendustin A | 3.29e-05 | 171 | 49 | 5 | CID000003894 | |
| Drug | IPSP | 3.70e-05 | 87 | 49 | 4 | CID000022083 | |
| Drug | NSC7524 | 4.43e-05 | 182 | 49 | 5 | CID000005657 | |
| Drug | 3-aminopropylphosphinic acid | 4.45e-05 | 32 | 49 | 3 | CID006335948 | |
| Drug | almagel | 4.52e-05 | 5 | 49 | 2 | CID003080942 | |
| Drug | S 8510 | 4.52e-05 | 5 | 49 | 2 | CID005488383 | |
| Drug | AC1L1H6N | 4.52e-05 | 5 | 49 | 2 | CID000003999 | |
| Drug | manidipine | 5.22e-05 | 95 | 49 | 4 | CID000004008 | |
| Drug | fluspirilene | 5.35e-05 | 34 | 49 | 3 | CID000003396 | |
| Drug | isotetrandrine | 5.66e-05 | 97 | 49 | 4 | CID000005422 | |
| Drug | homovanillic acid | 5.66e-05 | 97 | 49 | 4 | CID000001738 | |
| Drug | nitrendipine | 5.89e-05 | 98 | 49 | 4 | CID000004507 | |
| Drug | CP-80 | 6.36e-05 | 36 | 49 | 3 | CID000452640 | |
| Drug | isradipine | 6.38e-05 | 100 | 49 | 4 | CID000003784 | |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; HL60; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 3076_UP | |
| Drug | gamma-aminobutyric acid | 6.54e-05 | 474 | 49 | 7 | CID000000119 | |
| Drug | BAPTA | 6.62e-05 | 324 | 49 | 6 | CID000104751 | |
| Drug | 8-cyclopentyltheophylline | 7.49e-05 | 38 | 49 | 3 | CID000001917 | |
| Drug | AC1L1KS5 | 7.83e-05 | 334 | 49 | 6 | CID000005631 | |
| Drug | 4-aminopyrrolidine-2,4-dicarboxylate | 8.11e-05 | 39 | 49 | 3 | CID003331970 | |
| Drug | GF109203X | 8.78e-05 | 341 | 49 | 6 | CID000002396 | |
| Drug | AC1L1I54 | 9.43e-05 | 41 | 49 | 3 | CID000004426 | |
| Drug | Fk 888 | 1.01e-04 | 42 | 49 | 3 | CID000107967 | |
| Drug | phenytoin | 1.06e-04 | 219 | 49 | 5 | CID000001775 | |
| Drug | AC1NBU2S | 1.17e-04 | 117 | 49 | 4 | CID004473765 | |
| Drug | h PM | 1.25e-04 | 45 | 49 | 3 | CID005494424 | |
| Drug | NiCl2 | 1.25e-04 | 119 | 49 | 4 | CID000024385 | |
| Drug | KN-62 | 1.34e-04 | 230 | 49 | 5 | CID000003838 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 1.42e-04 | 233 | 49 | 5 | CID000005114 | |
| Drug | L024104 | 1.51e-04 | 48 | 49 | 3 | CID003025353 | |
| Drug | bepridil | 1.56e-04 | 126 | 49 | 4 | CID000002351 | |
| Drug | amlodipine | 1.56e-04 | 126 | 49 | 4 | CID000002162 | |
| Drug | CNQX | 1.56e-04 | 126 | 49 | 4 | CID000002821 | |
| Drug | pimozide | 1.61e-04 | 127 | 49 | 4 | CID000016362 | |
| Drug | KW-3049 | 1.71e-04 | 50 | 49 | 3 | CID000002324 | |
| Drug | cobalt-60 | 1.82e-04 | 390 | 49 | 6 | CID000061492 | |
| Drug | caffeine | 1.88e-04 | 562 | 49 | 7 | CID000002519 | |
| Drug | haloperidol | 1.93e-04 | 394 | 49 | 6 | CID000003559 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | 2.01e-04 | 568 | 49 | 7 | CID000000806 | |
| Drug | smilageninoside | 2.02e-04 | 10 | 49 | 2 | CID000197391 | |
| Drug | lanthanum | 2.09e-04 | 136 | 49 | 4 | CID000023926 | |
| Drug | 13-methoxyibogamine | 2.15e-04 | 54 | 49 | 3 | CID000065749 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | 2.21e-04 | 577 | 49 | 7 | CID000000295 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 4.30e-09 | 3 | 49 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 1.72e-08 | 4 | 49 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.50e-07 | 7 | 49 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 7.58e-06 | 163 | 49 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 4.04e-05 | 6 | 49 | 2 | C1854678 | |
| Disease | Myopathies, Nemaline | 7.52e-05 | 8 | 49 | 2 | C0206157 | |
| Disease | Bipolar Disorder | 1.34e-04 | 477 | 49 | 6 | C0005586 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 2.08e-04 | 13 | 49 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Pancytopenia | 8.56e-04 | 26 | 49 | 2 | C0030312 | |
| Disease | venous thromboembolism | 9.77e-04 | 460 | 49 | 5 | EFO_0004286 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RNGWNVMDFVVVLTG | 166 | O00555 | |
| VMQSYLEGVQTGVWQ | 71 | Q86VI1 | |
| QQWEGRQVMYQQSSG | 46 | Q9UM22 | |
| MVVGTAWIFLQGVYN | 481 | Q07001 | |
| VIGWYRFRRNTQQQM | 91 | Q15018 | |
| VINNTRFLMWDIGGQ | 56 | Q9Y689 | |
| GEDWNEVMYNGIRSQ | 656 | Q15878 | |
| GQETGIQWNNMYQAL | 3731 | Q86UQ4 | |
| GVYADMWQLQQGQEE | 816 | Q9NP58 | |
| NGLWVIYATEQNNGM | 271 | O95490 | |
| AGAMENWGLVTYREN | 351 | P15144 | |
| VRGEYGRAWNEVMLQ | 816 | Q5W041 | |
| YLRNGWNVMDFVVVL | 161 | Q00975 | |
| MLVVRNGQRVWEYLA | 721 | Q8TBY9 | |
| LYQSGGMQWDVAQRS | 4486 | Q99102 | |
| LVNWAVQVARGMNYL | 196 | Q02779 | |
| VLWQMGYTGANVRVA | 201 | Q14703 | |
| VYFQEQGHGDRWNMV | 201 | P09529 | |
| FLYGAMAQDVIWQNA | 1291 | Q14C86 | |
| NVQQIDDGWMYGTVE | 231 | Q14847 | |
| GVSWNTVRYMIGEVQ | 4101 | Q96JB1 | |
| GGYSWNNRCMVEIVQ | 551 | Q9P2J3 | |
| GRVNVVEALQEFWQM | 96 | Q8IVB5 | |
| GNQGLLYDRSWMVVN | 606 | Q96EN8 | |
| VGGAVYVYMNQQGRW | 386 | P23229 | |
| VGAYDWNGTVVMQKA | 396 | P56199 | |
| NVKNVMVVVSRWYGG | 256 | Q9P2X3 | |
| WQRQIMGAYLVRQGQ | 531 | Q96JP2 | |
| AQAMVDIVRALGWNY | 201 | O15303 | |
| VVGGYSWNNRCMVEI | 591 | Q9P2N7 | |
| NWLSGVNVVLVMAYG | 6 | Q9BWL3 | |
| QIGFEIRDMWYNLGQ | 1061 | Q14185 | |
| PGNQGYWVQEEMFRR | 1421 | Q8TD26 | |
| GWVNIMYNGLDAVAV | 1381 | Q9P0X4 | |
| MEVGQQAVEVWQGLA | 81 | P01588 | |
| YQNMGIWVQAENALG | 196 | Q99062 | |
| ILVNWAVQIARGMNY | 241 | P80192 | |
| GQVYRATWQGQEVAV | 136 | Q5TCX8 | |
| VLVNWAVQIARGMLY | 236 | Q5TCX8 | |
| NQQIVYMGWCEAREQ | 281 | Q9NSN8 | |
| GRQAVIYRWNDMGNI | 246 | Q15678 | |
| GVGNLRLGYWNQQMV | 241 | O00267 | |
| WRQLEQYMGQRGRIQ | 456 | P0DKV0 | |
| MRARQYPWGTVQVEN | 251 | Q14141 | |
| MFGLEAIWRNGQVVG | 836 | Q9UL12 | |
| LGIWSVMQRNYLQGE | 51 | Q9P126 | |
| NDNVVVTGWGTLYMN | 301 | Q86T26 | |
| IQVWLYEQVNMRIEG | 31 | P62304 | |
| REQIVGGDVQGYRWM | 501 | Q702N8 | |
| NVWNGMIGEVVYQRA | 491 | Q12879 | |
| AIINVQAIDEGWMYG | 6636 | P20929 | |
| QAIDEGWMYGTVQRT | 6641 | P20929 |